申请人:Xin Tao
公开号:US06897215B1
公开(公告)日:2005-05-24
Novel 6-bicyclopiperazinyl-1-arylsulfonylindole and 6-bicyclopiperidinyl-1-arylsulfonylindole compounds are disclosed which are useful as 5-HT
6
receptor antagonists in the treatment of central nervous system disorders such as schizophrenia, depression, ADHD, and cognition and memory dysfunction The compounds are Formula I
wherein: R1 is H or C
1-4
alkyl; X is CH, —C—OR3, ═C, or —N and Y is C-R2 or N; R3 is H or —C(O)-R4; R4 is H or a labile prodrug group; n is 1 or 2; m and o are, independently, 0, 1, or 2 with the proviso that m+o is 1 or 2; and Ar is an aryl or heteroaryl group optionally substituted with 1-3 substitutents.
本发明揭示了6-双环氧哌嗪基-1-芳烷磺酰基吲哚和6-双环氧哌啶基-1-芳烷磺酰基吲哚化合物,其在治疗中枢神经系统疾病如精神分裂症、抑郁症、注意力缺陷多动障碍和认知和记忆功能障碍中有用,这些化合物的化学式为I,其中:R1为H或C1-4烷基;X为CH,—C—OR3,═C或—N,Y为C-R2或N;R3为H或—C(O)-R4;R4为H或不稳定的前药基团;n为1或2;m和o独立地为0、1或2,但m+o为1或2;Ar为芳基或杂芳基,可选地取代1-3个取代基。